Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award: Canada Graduate Scholarships

McGill University

$120,000.00

Multimodal in vivo imaging of tauopathy in temporal lobe epilepsy: clinical and cognitive associations

EF 2024-25

Résumé
Temporal lobe epilepsy (TLE) is the most common seizure disorder that is resistant to medical therapy and is associated with memory, language, and attentional difficulties. The underlying reason for this cognitive decline is unclear, but past work has shown a link between Alzheimer's disease (AD), a neurodegenerative disorder, and epilepsy. Tau, a protein involved in the pathophysiology of AD, has been found in surgical tissue obtained from epilepsy patients and furthermore has been related to worsening cognitive function. One positron emission tomography (PET) radioligand that could be used to image tau in the entire brain in patients and healthy individuals is [18F]MK6240, giving a global view of tau in individuals that could be compared with other imaging studies. Studies using this radioligand have focused on AD and none thus far have looked at epilepsy. Using [18F]MK6240 PET and comparing with other PET and structural and functional magnetic resonance imaging (MRI) markers already known to be involved in TLE, we propose to address the following questions: 1) Do TLE patients show increased tau in comparison to healthy individuals and to what extent? 2) What is the relation between tau increases and other established structural and functional imaging abnormalities seen in TLE patients? And 3) Combining tau imaging and these other established imaging markers, can we predict cognitive and clinical outcomes, such memory scores, post-surgical seizure freedom, and underlying pathology, in TLE patients? Our work will be the first to look at tau in epilepsy patients and aims to give us insight into the neurobiological underpinnings of cognitive impairment using a multimodal imaging approach. Furthermore, this work will help us to predict cognitive and clinical outcomes allowing us to stratify patients for surgery. Finally, these findings will guide the development of novel medications targeting tau in epilepsy patients, offering new, promising treatment avenues.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
518944
Name
Lam Jackie
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Doctoral Research Awards - A
Projecttitle
Multimodal in vivo imaging of tauopathy in temporal lobe epilepsy: clinical and cognitive associations
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Cognitive; Epilepsy; Magnetic Resonance Imaging; Multimodal; Neuroimaging; Outcomes; Positron Emission Tomography
Abstract
Temporal lobe epilepsy (TLE) is the most common seizure disorder that is resistant to medical therapy and is associated with memory, language, and attentional difficulties. The underlying reason for this cognitive decline is unclear, but past work has shown a link between Alzheimer's disease (AD), a neurodegenerative disorder, and epilepsy. Tau, a protein involved in the pathophysiology of AD, has been found in surgical tissue obtained from epilepsy patients and furthermore has been related to worsening cognitive function. One positron emission tomography (PET) radioligand that could be used to image tau in the entire brain in patients and healthy individuals is [18F]MK6240, giving a global view of tau in individuals that could be compared with other imaging studies. Studies using this radioligand have focused on AD and none thus far have looked at epilepsy. Using [18F]MK6240 PET and comparing with other PET and structural and functional magnetic resonance imaging (MRI) markers already known to be involved in TLE, we propose to address the following questions: 1) Do TLE patients show increased tau in comparison to healthy individuals and to what extent? 2) What is the relation between tau increases and other established structural and functional imaging abnormalities seen in TLE patients? And 3) Combining tau imaging and these other established imaging markers, can we predict cognitive and clinical outcomes, such memory scores, post-surgical seizure freedom, and underlying pathology, in TLE patients? Our work will be the first to look at tau in epilepsy patients and aims to give us insight into the neurobiological underpinnings of cognitive impairment using a multimodal imaging approach. Furthermore, this work will help us to predict cognitive and clinical outcomes allowing us to stratify patients for surgery. Finally, these findings will guide the development of novel medications targeting tau in epilepsy patients, offering new, promising treatment avenues.
Competitiondate
202411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lam, Jackie
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~